A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis
about
Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trialsAn appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritisPersistence with golimumab in immune-mediated rheumatic diseases: a systematic review of real-world evidence in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritisTumor necrosis factor-α (TNFα) inhibitors in the treatment of nonradiographic axial spondyloarthritis: current evidence and place in therapy.The term 'non-radiographic axial spondyloarthritis' is much more important to classify than to diagnose patients with axial spondyloarthritis.Golimumab for treatment of axial spondyloarthritis.Challenges of diagnosis and management of axial spondyloarthritis in North Africa and the Middle East: An expert consensus.New treatment options and emerging drugs for axial spondyloarthritis: biological and targeted synthetic agents.Golimumab: A Review in Inflammatory Arthritis.Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis.ASAS classification criteria for axial spondyloarthritis: time to modify.The role of MRI in the evaluation of spondyloarthritis: a clinician's guide.Imaging findings suggestive of axial spondyloarthritis in diffuse idiopathic skeletal hyperostosis.Certolizumab pegol for treating axial spondyloarthritis.Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis.Therapies of Early, Advanced, and Late Onset Forms of Axial Spondyloarthritis, and the Need for Treat to Target Strategies.Ankylosing Spondylitis: HLA-B*27-Positive Versus HLA-B*27-Negative Disease.Patient Burden of Axial Spondyloarthritis.Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials.Nonradiographic axial spondyloarthritis: clinical and therapeutic relevance.Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.An update on biomarker discovery and use in axial spondyloarthritis.Treatment of Patients With Nonradiographic Axial Spondyloarthritis Who Have Negative Magnetic Resonance Imaging Results and Normal C-Reactive Protein Levels at Baseline: Comment on the Article by Ward et al.Real-World Treatment Patterns for Golimumab and Concomitant Medications in Japanese Rheumatoid Arthritis Patients.Feasibility and reliability of the Spondyloarthritis Research Consortium of Canada sacroiliac joint inflammation score in children.New advances in the understanding and treatment of axial spondyloarthritis: from chance to choice.Partial remission in ankylosing spondylitis and non-radiographic axial spondyloarthritis in treatment with infliximab plus naproxen or naproxen alone: associations between partial remission and baseline disease characteristics.Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland.Spotlight on certolizumab pegol in the treatment of axial spondyloarthritis: efficacy, safety and place in therapy.Ankylosing spondylitis and axial spondyloarthritis: recent insights and impact of new classification criteria.The role of golimumab in inflammatory arthritis. A review of the evidence
P2860
Q26738520-F3BCBE9E-9284-4204-8420-97D71229D432Q26741170-AC4771BB-5547-45AF-8734-DE8AF9470A8DQ33563272-1C8640C9-F56F-4AE9-836B-C51F8DB29B43Q38611064-218F2A57-F1AF-4776-AC84-47944DBD4024Q38696941-9ACC2E49-D3A3-4134-B4C3-47348CB680DAQ38707718-162AD2C9-C4F1-48BD-9FDA-46F48611314FQ38711954-9610512D-18D1-42E7-A468-32B9FEFDA9A8Q38768900-E6925090-024D-4F38-9CD3-91C5029B5D5DQ38771878-578AAFF8-0E13-4050-88EB-76392A6403C2Q38780258-3D4B6DAB-F511-4897-BFDB-AC702AE26041Q38812327-A9D1ADCB-80C2-4FEE-B71F-C6163777886EQ38812331-105F6476-2741-4985-9B36-E70DCDEFDD2AQ38858761-1EE4EF14-E3BD-4281-819E-F237434F2AE0Q38883124-C8ABD6C0-F23A-4E15-95C8-1A7245964B21Q38972623-4199F255-AFB8-498A-8735-F87BC0CF6AC3Q38998373-124FDE21-2680-4621-ADB2-B17B9728392BQ39135959-D00F1B28-F144-43C1-A67A-7AA95C906F3CQ39225803-D18C4361-FE4C-4F82-BD53-4649524BA350Q42365374-23955B88-DE5D-477A-987F-F282F15C27ABQ42376342-DE2470BD-12EA-4A02-825A-0F10C082917CQ47105493-FD990E82-BEC2-4B23-AE37-2E6BB6D50030Q47561517-8BDEA98C-69DB-46CD-A9B7-C1B8EA9639E1Q47787817-E8D89533-BDD1-4CBF-9CFD-202D20236B72Q48093961-3B19EF79-62C8-499A-94C6-FB8F4C6B5726Q51748891-F209CCAC-BC40-4A3F-A8BD-AB2D6506D0B7Q52642361-20671681-C940-4948-89E2-2143749FE029Q52670920-FC4B13BE-2C67-47F1-8042-79DCC2C9BFE7Q54624586-9E95E233-5073-4C2A-8B97-9C4394AF729EQ54994756-DA438774-22B7-4666-8874-8F3B533F39E6Q55073579-4837F1DD-0279-43DA-8F93-8B65DF2A299AQ55347433-A0AF63B0-3132-44CB-8F93-3FFBA81C3923Q58761668-51A4F799-085E-4F44-A156-37A63ACCA0AF
P2860
A randomized, double-blind, placebo-controlled, sixteen-week study of subcutaneous golimumab in patients with active nonradiographic axial spondyloarthritis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A randomized, double-blind, pl ...... raphic axial spondyloarthritis
@ast
A randomized, double-blind, pl ...... raphic axial spondyloarthritis
@en
type
label
A randomized, double-blind, pl ...... raphic axial spondyloarthritis
@ast
A randomized, double-blind, pl ...... raphic axial spondyloarthritis
@en
prefLabel
A randomized, double-blind, pl ...... raphic axial spondyloarthritis
@ast
A randomized, double-blind, pl ...... raphic axial spondyloarthritis
@en
P2093
P2860
P356
P1476
A randomized, double-blind, pl ...... raphic axial spondyloarthritis
@en
P2093
A Tzontcheva
M Dougados
W P Maksymowych
P2860
P304
P356
10.1002/ART.39257
P577
2015-07-02T00:00:00Z